The Rose Hill/Control Z LOI produces no measurable listed-equity move (>3%) in any named psychedelic ticker through August.

Two private companies signed a letter of intent (a non-binding agreement to potentially work together), but because neither company trades on a stock exchange, this news gives public investors nothing concrete to act on. Stock prices for publicly traded psychedelic companies like CMPS and MMED are driven by hard data — trial results, acquisitions — not private paperwork between outside firms. This prediction says none of the major listed psychedelic stocks will jump or drop more than 3% on any single day because of this deal memo.

Private LOIs between non-listed entities do not create public catalysts; institutional capital ignores them. Specific to today's LOI news and falsifiable against price data.